In a recent study, beta blockers appeared to significantly lower both the annualized risk for conversion from presymptomatic to symptomatic Huntington disease (HD) and the rate of worsening among ...

Please provide your email address to receive an email when new articles are posted on . Taking beta blockers may raise mortality risk for HSCT recipients due to suppression of signals from nerves that ...